Vitreomacular Adhesion
📧 Sign up to get email alerts when something new happens for Vitreomacular Adhesion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion [Phase 4]
Phase 4 trial update for ocriplasmin in vitreomacular traction and symptomatic vitreomacular adhesion; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2018-03-29Clinical Trial Update: Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
A completed clinical trial evaluating the prevalence of vitreomacular adhesion in patients aged 40 years and older. The study was sponsored …
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Assessment of Patients Treated With JETREA® for Vitreomacular Traction [Phase 4]
Phase 4 clinical trial update on Jetrea (ocriplasmin) for vitreomacular traction and vitreomacular adhesion; results were posted following c…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment [Phase 1]
A completed Phase 1 trial evaluating the safety and preliminary efficacy of Resolvine for vitreomacular attachment conditions.
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole [Phase 3]
Phase 3 trial results for ocriplasmin in symptomatic vitreomacular adhesion including macular hole have been completed and results posted in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA
This clinical trial update reports a retrospective chart review of patients treated with ocriplasmin for symptomatic vitreomacular adhesion.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial. [Phase 3]
Phase 3 trial evaluating intravitreal microplasmin for non-surgical treatment of focal vitreomacular adhesion completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial. [Phase 3]
Phase 3 trial results for intravitreal microplasmin (MIVI-TRUST, TG-MV-006) evaluating non-surgical treatment of focal vitreomacular adhesio…